Literature DB >> 29497578

The Benefit of Mirtazapine in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report.

Carola Mullins1,2,3, Jorge Miranda1,2,3, Hugo Sandoval1,2,3, Luis Ramos-Duran1,2,3, Silvina B Tonarelli1,2,3.   

Abstract

Highly active antiretroviral therapy is well-established in the treatment of human immunodeficiency virus (HIV)-positive patients. Nonadherence with therapy regimens often leads to the occurrence of opportunistic infections that further complicate treatment and challenge the treating physician. We report a young HIV-positive patient who suffered from progressive multifocal leukoencephalopathy caused by the human John Cunningham virus and showed objective clinical improvement after adding mirtazapine to the treatment regimen, an observation that is supported by the emerging literature.

Entities:  

Keywords:  Progressive multifocal leukoencephalopathy (PML); acquired immunodeficiency syndrome (AIDS); highly active antiretroviral therapy (HAART); human immunodeficiency virus (HIV); mirtazapine

Year:  2018        PMID: 29497578      PMCID: PMC5819719     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  9 in total

1.  Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.

Authors:  Susama Verma; Katia Cikurel; Igor J Koralnik; Susan Morgello; Charlotte Cunningham-Rundles; Zelig R Weinstein; Christine Bergmann; David M Simpson
Journal:  J Infect Dis       Date:  2007-07-13       Impact factor: 5.226

Review 2.  Brain plasticity and functional losses in the aged: scientific bases for a novel intervention.

Authors:  Henry W Mahncke; Amy Bronstone; Michael M Merzenich
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

3.  Progressive multifocal leucoencephalopathy in a patient with sarcoidosis--successful treatment with cidofovir and mirtazapine.

Authors:  K Owczarczyk; R Hilker; A Brunn; M Hallek; A Rubbert
Journal:  Rheumatology (Oxford)       Date:  2007-03-27       Impact factor: 7.580

Review 4.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

5.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.

Authors:  S Vulliemoz; F Lurati-Ruiz; F-X Borruat; J Delavelle; I J Koralnik; T Kuntzer; J Bogousslavsky; F Picard; T Landis; R A Du Pasquier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

6.  The human polyomavirus, JCV, uses serotonin receptors to infect cells.

Authors:  Gwendolyn F Elphick; William Querbes; Joslynn A Jordan; Gretchen V Gee; Sylvia Eash; Kate Manley; Aisling Dugan; Megan Stanifer; Anushree Bhatnagar; Wesley K Kroeze; Bryan L Roth; Walter J Atwood
Journal:  Science       Date:  2004-11-19       Impact factor: 47.728

7.  Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.

Authors:  M Lanzafame; S Ferrari; E Lattuada; F Corsini; R Deganello; S Vento; E Concia
Journal:  Infez Med       Date:  2009-03

8.  Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.

Authors:  Deanna Cettomai; Justin C McArthur
Journal:  Arch Neurol       Date:  2009-02

9.  Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images.

Authors:  A S Mark; S W Atlas
Journal:  Radiology       Date:  1989-11       Impact factor: 11.105

  9 in total
  2 in total

1.  Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions.

Authors:  Elena Augusta Vola; Maria Petracca; Sirio Cocozza; Marcello De Angelis; Antonio Carotenuto; Giuseppe Pontillo; Vincenzo Brescia Morra; Enrico Tedeschi; Roberta Lanzillo
Journal:  BMC Neurol       Date:  2021-04-05       Impact factor: 2.474

2.  Progressive multifocal leukoencephalopathy associated with chemotherapy induced lymphocytopenia in solid tumors - case report of an underestimated complication.

Authors:  Patrick Mayr; Mathias Lutz; Maximilian Schmutz; Jens Hoeppner; Friederike Liesche-Starnecker; Jürgen Schlegel; Jochen Gaedcke; Rainer Claus
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.